Greg Tourangeau - Net Worth and Insider Trading

Greg Tourangeau Net Worth

The estimated net worth of Greg Tourangeau is at least $71,624 dollars as of 2024-07-07. Greg Tourangeau is the Principal Accounting Officer of Fulcrum Therapeutics Inc and owns about 11,571 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $71,624. Details can be seen in Greg Tourangeau's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Greg Tourangeau has not made any transactions after 2024-05-07 and currently still holds the listed stock(s).

Transaction Summary of Greg Tourangeau

To

Greg Tourangeau Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Greg Tourangeau owns 1 companies in total, including Fulcrum Therapeutics Inc (FULC) .

Click here to see the complete history of Greg Tourangeau’s form 4 insider trades.

Insider Ownership Summary of Greg Tourangeau

Ticker Comapny Transaction Date Type of Owner
FULC Fulcrum Therapeutics Inc 2024-05-07 Controller

Greg Tourangeau Latest Holdings Summary

Greg Tourangeau currently owns a total of 1 stock. Greg Tourangeau owns 11,571 shares of Fulcrum Therapeutics Inc (FULC) as of May 7, 2024, with a value of $71,624.

Latest Holdings of Greg Tourangeau

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FULC Fulcrum Therapeutics Inc 2024-05-07 11,571 6.19 71,624

Holding Weightings of Greg Tourangeau


Greg Tourangeau Form 4 Trading Tracker

According to the SEC Form 4 filings, Greg Tourangeau has made a total of 3 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Fulcrum Therapeutics Inc is the sale of 236 shares on May 7, 2024, which brought Greg Tourangeau around $1,831.

Insider Trading History of Greg Tourangeau

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Greg Tourangeau Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Greg Tourangeau Ownership Network

Ownership Network List of Greg Tourangeau

No Data

Ownership Network Relation of Greg Tourangeau

Insider Network Chart

Greg Tourangeau Owned Company Details

What does Fulcrum Therapeutics Inc do?

Who are the key executives at Fulcrum Therapeutics Inc?

Greg Tourangeau is the Controller of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include director & See Remarks Alex Sapir , Chief Financial Officer Alan A Musso , and 10 percent owner Ra Capital Healthcare Fund Lp .

Fulcrum Therapeutics Inc (FULC) Insider Trades Summary

Over the past 18 months, Greg Tourangeau made 3 insider transaction in Fulcrum Therapeutics Inc (FULC) with a net sale of 5,330. Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net purchase of 1,923,076 shares made by Ra Capital Healthcare Fund Lp , a net purchase of 43,360 shares made by Alex Sapir , and a net sale of 6,766 shares made by Robert J Gould .

In summary, during the past 3 months, insiders sold 236 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 236 shares. During the past 18 months, 12,096 shares of Fulcrum Therapeutics Inc (FULC) were sold and 1,966,436 shares were bought by its insiders, resulting in a net purchase of 1,954,340 shares.

Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Fulcrum Therapeutics Inc Insider Transactions

No Available Data

Greg Tourangeau Mailing Address

Above is the net worth, insider trading, and ownership report for Greg Tourangeau. You might contact Greg Tourangeau via mailing address: C/o Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge Ma 02139.

Discussions on Greg Tourangeau

No discussions yet.